The Role of nab-Paclitaxel Plus Gemcitabine Therapy for Recurrent Pancreatic Cancer Refractory to Gemcitabine and S-1

被引：0
|
作者：
Kagawa, S. [1 ]
Yoshitomi, H. [1 ]
Shimizu, H. [1 ]
Ohtsuka, M. [1 ]
Kato, A. [1 ]
Furukawa, K. [1 ]
Takayashiki, T. [1 ]
Takano, S. [1 ]
Kuboki, S. [1 ]
Suzuki, D. [1 ]
Sakai, N. [1 ]
Miyazaki, M. [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan
来源：
PANCREAS | 2015年 / 44卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1385 / 1385
页数：1
相关论文
共 50 条
  • [31] Comparative effectiveness of gemcitabine vs gemcitabine plus nab-paclitaxel vs FOLFIRINOX for unresectable pancreatic cancer
    Yamamoto, Shun
    Ueno, Hideki
    Tanaka, Midori
    Inagaki, Yuji
    Ohba, Akihiro
    Sakamoto, Yasunari
    Kondo, Shunsuke
    Morizane, Chigusa
    Okusaka, Takuji
    ANNALS OF ONCOLOGY, 2017, 28
  • [32] Predictors of vulnerability to nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Iede, Kiyotsugu
    Yamada, Terumasa
    Tominaga, Shusei
    ANNALS OF ONCOLOGY, 2023, 34 : S1453 - S1453
  • [33] Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga
    Torregroza-Sanchez, Maria Patricia
    Bedoya-Apraez, Ivan Dario
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (02) : E16 - E18
  • [34] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Tsujimoto, Akiko
    Sudo, Kentaro
    Nakamura, Kazuyoshi
    Kita, Emiri
    Hara, Ryusuke
    Takayama, Wataru
    Ishii, Hiroshi
    Yamaguchi, Taketo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [35] Survival of patients with advanced pancreatic cancer is increased by nab-paclitaxel plus gemcitabine
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 (12) : 695 - 695
  • [36] Nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreatic cancer: our experience
    Mare, M.
    Munao, S.
    Germana, S.
    Colarossi, C.
    Sciacca, D.
    Giuffrida, D.
    Giannone, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Akiko Tsujimoto
    Kentaro Sudo
    Kazuyoshi Nakamura
    Emiri Kita
    Ryusuke Hara
    Wataru Takayama
    Hiroshi Ishii
    Taketo Yamaguchi
    Scientific Reports, 9
  • [38] Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine
    Ceccon, Garry
    Wollring, Michael
    Brunn, Anna
    Deckert, Martina
    Waldschmidt, Dirk
    Fink, Gereon R.
    Galldiks, Norbert
    CASE REPORTS IN ONCOLOGY, 2020, 13 (01): : 35 - 42
  • [39] Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-na?ve advanced pancreatic ductal adenocarcinoma
    Zhou Zhu
    Hui Tang
    Jinrong Ying
    Yuejuan Cheng
    Xiang Wang
    Yingyi Wang
    Chunmei Bai
    Cancer Biology & Medicine, 2023, 20 (10) : 765 - 778
  • [40] Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-na?ve advanced pancreatic ductal adenocarcinoma
    Zhou Zhu
    Hui Tang
    Jinrong Ying
    Yuejuan Cheng
    Xiang Wang
    Yingyi Wang
    Chunmei Bai
    Cancer Biology & Medicine, 2023, (10) : 765 - 778
12345